CLX Financial Statements & Analysis
Complete financial statements for CLX including income statement, balance sheet, and cash flow statement. Analyze CLX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
72
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
0.2% ↑
Net Income
189.3% ↑
Gross Margin
5.3% ↑
Operating Margin
114.5% ↑
Balance Sheet
Current Ratio
-18.7% ↓
Debt to Equity
1.4% ↓
Asset Turnover
3.6% ↑
Cash Flow
Operating Cash Flow
41.2% ↑
Net Cash Flow
77.0% ↑
Free Cash Flow
57.6% ↑
Cash Flow to Debt
42.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 7.09B | 7.10B | 0.2% | |
| Gross Profit | 3.05B | 3.21B | 5.4% | |
| Operating Income | 916.00M | 1.97B | 114.8% | |
| Net Income | 280.00M | 810.00M | 189.3% | |
| EPS | 2.25 | 6.56 | 191.6% | |
| EBITDA | 736.00M | 1.17B | 58.4% | |
| Gross Margin | 42.97% | 45.23% | 5.3% | |
| Operating Margin | 12.91% | 27.70% | 114.5% | |
| Net Income Margin | 3.95% | 11.40% | 188.8% | |
| R&D Expenses | 126.00M | 121.00M | 4.0% |
Income Statement Full Table
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 7.10B | 7.09B | 7.39B | 7.11B | 7.34B |
| Gross Profit | 3.21B | 3.05B | 2.91B | 2.54B | 3.20B |
| Operating Income | 1.97B | 916.00M | 1.22B | 489.00M | 1.12B |
| Net Income | 810.00M | 280.00M | 149.00M | 462.00M | 710.00M |
| EPS | 6.56 | 2.25 | 1.21 | 3.75 | 5.65 |
| EBITDA | 1.17B | 736.00M | 577.00M | 928.00M | 1.20B |
| Gross Margin | 45.23% | 42.97% | 39.36% | 35.81% | 43.58% |
| Operating Margin | 27.70% | 12.91% | 16.57% | 6.88% | 15.22% |
| Net Income Margin | 11.40% | 3.95% | 2.02% | 6.50% | 9.67% |
| R&D Expenses | 121.00M | 126.00M | 138.00M | 132.00M | 149.00M |